We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$2.13B
AUM Growth
+$54.9M
Cap. Flow
-$67.8M
Cap. Flow %
-3.18%
Top 10 Hldgs %
35.96%
Holding
279
New
53
Increased
73
Reduced
109
Closed
37

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$39M
2
AXP icon
American Express
AXP
+$36.3M
3
ATI icon
ATI
ATI
+$31M
4
CMI icon
Cummins
CMI
+$27.1M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$22.1M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$64.3M
2
AMD icon
Advanced Micro Devices
AMD
+$41.9M
3
PSX icon
Phillips 66
PSX
+$41.4M
4
P
Everpure Inc
P
+$34.9M
5
BAH icon
Booz Allen Hamilton
BAH
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 24.48%
2 Industrials 17.26%
3 Financials 15.99%
4 Healthcare 12.99%
5 Consumer Discretionary 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TOL icon
26
Toll Brothers
TOL
$13.6B
$28.4M 1.33%
183,561
+1,631
+0.9% +$221K
ACGL icon
27
Arch Capital
ACGL
$34.3B
$26.1M 1.22%
233,144
-467
-0.2% -$48.6K
UBER icon
28
Uber
UBER
$143B
$25.4M 1.19%
338,221
-4,565
-1% -$321K
RL icon
29
Ralph Lauren
RL
$22.6B
$23.1M 1.08%
119,085
-378
-0.3% -$65.4K
TEVA icon
30
Teva Pharmaceuticals
TEVA
$40.8B
$22.8M 1.07%
+1,263,472
New +$22.1M
CRBG icon
31
Corebridge Financial
CRBG
$14.1B
$22.6M 1.06%
774,104
+187,559
+32% +$5.3M
BKNG icon
32
Booking.com
BKNG
$149B
$21.8M 1.02%
129,450
-1,350
-1% -$207K
BSX icon
33
Boston Scientific
BSX
$69.5B
$21.6M 1.01%
257,205
+4,116
+2% +$324K
VTR icon
34
Ventas
VTR
$48B
$21M 0.98%
+326,860
New +$19.1M
TTEK icon
35
Tetra Tech
TTEK
$8.49B
$20.4M 0.96%
432,616
+393,566
+1,008% +$17.5M
STNG icon
36
Scorpio Tankers
STNG
$3.87B
$19.7M 0.93%
276,838
-795
-0.3% -$58.1K
AXON
37
Axon Enterprise
AXON
$42.5B
$19.5M 0.91%
48,777
-592
-1% -$204K
MSI icon
38
Motorola Solutions
MSI
$72.3B
$18.6M 0.87%
41,437
+886
+2% +$369K
SSNC icon
39
SS&C Technologies
SSNC
$18.6B
$18.5M 0.87%
+249,720
New +$17.7M
HALO icon
40
Halozyme
HALO
$9.79B
$18.1M 0.85%
+315,378
New +$18.1M
EXP icon
41
Eagle Materials
EXP
$6.29B
$17.3M 0.81%
60,266
-16
-0% -$4K
OSCR icon
42
Oscar Health
OSCR
$9.41B
$15.8M 0.74%
746,241
+10,433
+1% +$188K
KKR icon
43
KKR & Co
KKR
$91.1B
$15.2M 0.71%
116,547
-429
-0.4% -$50.8K
OHI icon
44
Omega Healthcare
OHI
$15.1B
$14.4M 0.67%
+353,244
New +$13.4M
GLW icon
45
Corning
GLW
$119B
$14.3M 0.67%
+316,842
New +$13.3M
FRPT icon
46
Freshpet
FRPT
$2.93B
$13.5M 0.63%
+98,751
New +$12.9M
ARGX icon
47
argenx
ARGX
$53.4B
$12.8M 0.6%
+23,566
New +$11.9M
ALL icon
48
Allstate
ALL
$68B
$12.5M 0.59%
65,876
+15,349
+30% +$2.73M
GS icon
49
Goldman Sachs
GS
$300B
$12.1M 0.57%
+24,431
New +$11.9M
ONON icon
50
On Holding
ONON
$12.1B
$11.9M 0.56%
+237,365
New +$10.2M
1
2
3 4 5

Similar funds

MB
MUFG Bank Tokyo 100-8388,, Japan $3.04B AUM 15.55% 1-Year Est. Return
MCM
MKP Capital Management New York $3.04B AUM 20.46% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return

Cookson Peirce & Co's Q3 2024 Portfolio in Review

As of Q3 2024, Cookson Peirce & Co held 279 positions worth $2.13B, up 2.6% from $2.08B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Cookson Peirce & Co withdrew a net $67.8M in Q3 2024, closing 37 positions and reducing 109 holdings. Its most notable exit was Merck, an estimated $64.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 30% a quarter earlier, followed by Industrials and Financials.

Against the trend, Cookson Peirce & Co opened a new position in AstraZeneca worth $37.7M.

  • Cookson Peirce & Co's largest Q3 2024 buy was AstraZeneca: 241,834 shares worth $37.7M.
  • Cookson Peirce & Co added most to American Express in Q3 2024, an estimated $36.3M increase.
  • Cookson Peirce & Co's biggest Q3 2024 reduction was Phillips 66, cutting an estimated $41.4M.
  • Cookson Peirce & Co fully exited Merck in Q3 2024, selling an estimated $64.3M.
  • Cookson Peirce & Co's ten largest holdings make up 36% of its $2.13B portfolio in Q3 2024.
  • Cookson Peirce & Co opened 53 new positions and closed 37 in Q3 2024.
  • Cookson Peirce & Co's portfolio value rose 2.6% quarter-over-quarter to $2.13B.

Based on Cookson Peirce & Co's 13F filing for Q3 2024, filed 12 Nov 2024.